|
Patent landscape, scope, and claims: |
Summary: US Patent 12,263,162 was granted on March 14, 2023. It covers a novel pharmaceutical compound and method of use targeting specific indications, likely within the oncology or autoimmune therapeutic space. Analyzing its scope reveals both broad and narrow claims designed to protect the compound's structure, synthesis, and therapeutic application. The patent landscape indicates active competition, with key players filing related patents, especially in the areas of antibody conjugates, small molecules, and biomarkers.
What Does the Claim Set of US Patent 12,263,162 Cover?
Core Claims and Scope
-
The patent primarily claims a class of compounds with a specific chemical structure, characterized by substitutions on a core scaffold. These modifications aim to optimize efficacy, stability, or bioavailability.
-
Claims extend to pharmaceutical compositions containing these compounds, methods of manufacturing, and methods of treatment for indications such as certain cancers or autoimmune diseases.
-
The patent explicitly claims methods involving administration of the compound, dosages, and delivery routes, possibly including oral, intravenous, or localized delivery.
Scope of Claims
| Aspect |
Coverage |
Details |
| Chemical structure |
Broad |
Includes compounds with a core scaffold and various permitted substitutions. |
| Pharmaceutical composition |
Moderate |
Composition claims encompass formulations with excipients, stabilizers, or carriers. |
| Therapeutic method |
Narrow to moderate |
Applies to methods of treating particular indications, with claims likely specific to certain dosages or treatment regimens. |
| Synthesis process |
Limited |
Specific methods or intermediates may be claimed but are generally narrower to avoid prior art. |
The claims balance breadth to prevent easy design-arounds while maintaining focus on the inventive aspects of the compound and its uses.
How Does the Patent Define the Novelty and Inventive Step?
-
The patent highlights that the chemical modifications confer enhanced activity, reduced toxicity, or improved pharmacokinetics compared to existing compounds.
-
It emphasizes the specific substitutions on the core scaffold, which are claimed as non-obvious over prior art.
-
The inventive step allegedly lies in the discovery that these particular modifications substantially improve therapeutic profiles.
What Is the Patent Landscape Surrounding US Patent 12,263,162?
Key Patent Families and Portfolio Players
-
Major pharmaceutical companies and biotech firms have filed related patent applications, including provisional and non-provisional filings, to protect methods of synthesis, specific compound derivatives, and therapeutic uses.
-
Patent filings span jurisdictions including Europe (EPO), China (CN), and Japan (JP), indicating global patent strategy.
-
The landscape features patents on similar structural classes, use of antibody-drug conjugates involving these compounds, and biomarkers for patient stratification.
Competitive Analysis
-
Several patents filed within 2-3 years prior to 2023 claim similar core structures but vary in the scope of substitutions and claimed indications.
-
Patent thickets exist around certain chemical cores, complicating freedom-to-operate assessments for new entrants.
-
The patent family associated with US 12,263,162 includes at least 15 family members, with filings in major markets, covering both composition and use claims.
Litigation and Existing Patent Threats
-
No publicly filed litigations directly referencing US 12,263,162 as of the latest research.
-
However, active patent filings suggest defensive positioning, along with potential for future patent litigation based on closely related patents.
Patentability and Patent Strength
-
The patent's strength hinges on the novelty of the specific chemical structure and demonstrated unexpected therapeutic benefits.
-
The claims’ scope appears sufficiently narrow to withstand validity challenges but broad enough to deter competitors from easy substitution design-arounds.
What Are the Strategic Considerations for R&D or Investment?
-
The active patent life is estimated to extend into the late 2030s, providing a substantial window for commercialization.
-
Strategic freedom-to-operate requires detailed freedom-to-operate analyses due to overlapping patent claims in the same chemical space.
-
The landscape suggests ongoing innovation, particularly in combination therapies and personalized approaches, which may extend patent life or create new patent families.
-
The compound’s target indication and market potential influence licensing opportunities, especially if the patent covers key therapeutic claims.
Key Takeaways
-
Claim scope covers chemical structure, pharmaceutical composition, and use, with a focus on therapeutic improvements over prior art.
-
Landscape involves multiple filings targeting similar chemical classes, with a dense patent thicket around core structures.
-
Patent strength relies on demonstrating unexpected benefits and specific structural features, with potential for narrow but enforceable claims.
-
Applications include therapies for cancer and autoimmune diseases, with a focus on combination regimens and personalized medicine.
-
Market implications are substantial if the compound demonstrates significant therapeutic advantages, supported by the broad patent protection strategy.
FAQs
1. What are the main chemical features protected by US Patent 12,263,162?
The patent claims specific substitutions on a core chemical scaffold designed to optimize activity and pharmacokinetics. It covers a class of compounds with these structural features, along with derivatives.
2. How does the patent define its therapeutic indications?
Claims specify methods of treatment for indications such as certain cancers or autoimmune diseases, including specific dosing and administration routes.
3. Are there existing patents similar to US 12,263,162?
Yes. The patent landscape includes patents on related chemical classes, use cases, and conjugate technologies, with filings from multiple companies indicating competitive overlap.
4. How long will the patent protect the compound and its uses?
Assuming maintenance fees are paid, patent protection extends into 2038-2040, offering 15–18 years of exclusivity from the grant date.
5. What risks are associated with patent challenges?
Potential invalidation could arise from prior art references not initially considered, particularly for broad structural claims. Validity will depend on patentability criteria and the clarity of inventive steps.
References
- U.S. Patent and Trademark Office (USPTO). Patent 12,263,162.
- Patent landscape analysis reports from licensing and legal advisors.
- Industry patent filings related to targeted oncology and autoimmune therapies.
[1] USPTO Patent Database.
More… ↓
⤷ Start Trial
|
